Product category:
Microplate readers
News Release from: TTP LabTech | Subject: Acumen eX3
Edited by the Laboratorytalk Editorial
Team on 09 April 2008
Acumen eX3 speeds up genome-wide
screening
TTP LabTech reports that Cancer Research UK (CRUK) has recently purchased an Acumen eX3 microplate cytometer to run an RNAi whole genome screen to identify cytotoxic survival regulators
The Cancer Research UK's London Research Institute (LRI) has recently established a high-throughput screening facility to enable its research groups to easily access genome-wide siRNA and RNAi screening technologies The 46 research groups at the LRI are engaged in innovative biological research to improve understanding of cancer
This article was originally published on Laboratorytalk on 21 Sep 2006 at 8.00am (UK)
Related stories
Triple laser microplate cytometer suits HCS
TTP LabTech initiated the second generation of high content screening (HCS) systems with the launch of the triple laser Acumen eX3 microplate cytometer at SBS 2006
Screening innovation drives big orders
Following the significant interest generated in the Acumen eX3 microplate cytometer at its SBS launch in late 2006, TTP LabTech has revealed that sales have reached US$2m for the quarter
The techniques employed are hugely varied and encompass approaches using anything from yeast to flies to human cells.
The human genome siRNA collection contains approximately 22,000 genes spread over some 267 96-well plates; and a typical genome screen in triplicate would require 801 plates to be analysed.
Therefore the LRI facility needs equipment that is robust, capable of high-throughput and very flexible to accommodate all of the possible interests of the research groups.
"Our extended trial of the Acumen eX3 demonstrated that it met all of these needs.
"In the immediate future it will enable us to perform very complicated assays measuring 20-30 cell cycle related parameters for every cell in every well of every plate" said the LRI's Mike Howell.
"In the longer term we can see applications across a whole range of assays, species and cell types including multi-parametric analysis of mixed cell populations, wound healing assays and cell adhesion assays".
The Acumen eX3 will be used to complement the existing infrastructure of automated microscopes, but will also be used as an investigative tool in its own right.
The high throughputs achieved by the Acumen eX3 means that to screen the whole genome will take days, compared to the same screen taking at least two years on a flow-based instrument.
It can read an entire 384-well plate in under ten minutes, and this includes multiplexing the assay with other biomarkers.
A recent study (Kittler, R et al, Nature Cell Biology 2007; 9: 1401-1412) looking at genome-scale RNAi profiling of cell division in human tissue culture cells was screened on an Acumen microplate cytometer.
The siRNA library targeted 17,828 genes, and identified 252 previously uncharacterised genes as being involved in the regulation of the cell cycle.
• TTP LabTech: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
